GNH USA

Europe — EMA

Ondansetron Kabi (Ondansetron Hydrochloride Dihydrate)

GNH USA supplies Ondansetron Kabi (Ondansetron), a 5‑HT3 receptor antagonist for preventing chemotherapy, radiotherapy and surgical nausea. Request a quote.

Ondansetron Hydrochloride Dihydrate

Request sourcing

1
Pack/s

What is Ondansetron Hydrochloride Dihydrate?

Ondansetron Hydrochloride Dihydrate, the active ingredient in Ondansetron Kabi, is a serotonin 5‑HT3 receptor antagonist presented as an intravenous solution for intravenous use. It is employed to prevent and treat nausea and vomiting caused by chemotherapy, radiotherapy, and postoperative conditions in adult patients.

GNH USA supplies Ondansetron Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution.

What is Ondansetron Hydrochloride Dihydrate used for?

Ondansetron Kabi is an antiemetic that acts on the serotonin 5‑HT3 pathway to control nausea and vomiting.

- Chemotherapy‑induced nausea and vomiting: prevents and treats nausea and vomiting associated with cytotoxic chemotherapy. - Radiotherapy‑induced nausea and vomiting: reduces nausea and vomiting that occur during or after radiotherapy. - Postoperative nausea and vomiting: helps prevent nausea and vomiting following surgical procedures.

What are the side effects of Ondansetron Hydrochloride Dihydrate?

Common Side Effects: - Headache: mild to moderate headache may occur. - Constipation: reduced bowel motility leading to hard stools. - Dizziness: transient sensation of light‑headedness. - Fatigue: feeling unusually tired or weak. - Injection site reactions: mild pain or erythema at the IV site.

Serious or Rare Side Effects: - QT interval prolongation: may predispose to cardiac arrhythmias. - Severe allergic reaction: anaphylaxis, rash, or angioedema. - Cardiac arrhythmia: potentially life‑threatening rhythm disturbances.

What precautions apply to Ondansetron Hydrochloride Dihydrate?

Precautions should be observed when using Ondansetron Kabi to ensure patient safety.

- Assess cardiac risk: monitor QT interval in patients with known prolongation or electrolyte disturbances. - Avoid use in hypersensitivity: discontinue immediately if an allergic reaction occurs. - Use caution in hepatic impairment: dose adjustment may be required for patients with severe liver disease. - Consider renal function: monitor closely in patients with significant renal failure. - Pregnancy: safety not established; use only if potential benefit justifies the risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Ondansetron Hydrochloride Dihydrate interact with?

Drug interactions may affect the safety and efficacy of Ondansetron Kabi.

Major Interactions (Avoid): - Apomorphine: may cause severe hypotension and loss of consciousness. - Concomitant QT‑prolonging agents: increased risk of serious cardiac arrhythmias. - Ritonavir: can raise plasma concentrations of ondansetron.

Moderate Interactions (Monitor Closely): - Corticosteroids: may enhance antiemetic effect, requiring dose reassessment. - Aminoglycosides: may increase risk of ototoxicity. - Anticholinergics: may reduce ondansetron's efficacy.

Frequently asked questions

What is Ondansetron Kabi used for?+
Ondansetron Kabi is an intravenous antiemetic indicated for the prevention and treatment of nausea and vomiting associated with chemotherapy, radiotherapy, and postoperative recovery. It is commonly used in oncology and surgical settings to improve patient comfort and reduce the risk of emesis.
How does Ondansetron work?+
Ondansetron works by selectively blocking serotonin (5‑HT3) receptors located in the central nervous system and the gastrointestinal tract. This inhibition prevents serotonin‑mediated activation of the chemoreceptor trigger zone and vagal afferents, thereby reducing the neural signals that cause nausea and vomiting.
What is the usual dose of Ondansetron Kabi?+
The dose of Ondansetron Kabi is determined by the prescribing clinician based on the specific clinical situation, such as the type of chemotherapy or surgical procedure. The prescriber will select the appropriate amount, timing, and infusion rate for each patient.
Is Ondansetron Kabi safe in pregnancy or breastfeeding?+
Safety data for Ondansetron Kabi in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.
How do I order Ondansetron Kabi from GNH USA?+
To order Ondansetron Kabi, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain requirements) and import documentation.
How does Ondansetron compare with other antiemetic classes?+
Ondansetron belongs to the 5‑HT3 antagonist class, which is highly effective for chemotherapy‑induced and postoperative nausea. Compared with dopamine antagonists (e.g., metoclopramide) or corticosteroids (e.g., dexamethasone), ondansetron offers a more targeted mechanism with fewer extrapyramidal side effects, though it may carry a risk of QT prolongation.
What are the storage and handling requirements for Ondansetron Kabi?+
Ondansetron Kabi should be stored at 2‑8 °C, protected from light, and kept in its original packaging. Do not freeze or shake the solution. Before administration, allow the product to reach room temperature if required, and inspect for any particulate matter or discoloration.
How is Ondansetron Kabi administered?+
Ondansetron Kabi is given as an intravenous infusion. The solution is typically diluted in compatible IV fluids and administered over a few minutes, as directed by the prescriber. Administration should follow aseptic technique and be performed by qualified healthcare personnel.
What are the most serious risks associated with Ondansetron Kabi?+
The most serious risks include QT interval prolongation, which can lead to potentially fatal cardiac arrhythmias, and severe hypersensitivity reactions such as anaphylaxis. Patients with known congenital long QT syndrome or those receiving other QT‑prolonging drugs should be monitored closely.
Who should not use Ondansetron Kabi?+
Ondansetron Kabi should be avoided in patients with a known hypersensitivity to ondansetron or any component of the formulation, and in individuals with congenital long QT syndrome or uncontrolled electrolyte imbalances that predispose to cardiac arrhythmias.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Ondansetron Hydrochloride Dihydrate
Route
Intravenous Use
Manufacturer
Fresenius Kabi Deutschland Gmbh
Origin
EU

Related products

Cellondan

Cellondan

Ondansetron Hydrochloride Dihydrate

Stadapharm Gmbh
EU
Cellondan

Cellondan

Ondansetron Hydrochloride Dihydrate

Stadapharm Gmbh
EU
Emeset

Emeset

Ondansetron Hydrochloride Dihydrate

Amring Farma Srl
EU
Emetron

Emetron

Ondansetron Hydrochloride Dihydrate

Gedeon Richter Plc.
EU